GoHealth Receives Nasdaq Delisting Notice for Failing to Meet Minimum Market Value Requirement
summarizeSummary
GoHealth, Inc. received a Nasdaq delisting notice for failing to meet the $35 million minimum market value requirement, initiating a 180-day compliance period to avoid potential delisting.
check_boxKey Events
-
Nasdaq Delisting Notice Received
On March 18, 2026, GoHealth, Inc. received a notice from Nasdaq's Listing Qualifications Department regarding non-compliance with listing rules.
-
Failure to Meet MVLS Requirement
The company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires a minimum market value of listed securities of $35 million. It also fails to meet alternative listing standards for stockholders' equity or net income.
-
180-Day Compliance Period
GoHealth has been granted a 180-calendar day period, until September 14, 2026, to regain compliance. This requires its market value to close at $35 million or more for at least 10 consecutive business days.
-
Risk of Delisting
If compliance is not regained, Nasdaq will issue a delisting notice. The company may appeal this determination, but there is no assurance it will be able to maintain its listing.
auto_awesomeAnalysis
GoHealth, Inc. has received a formal notice from Nasdaq indicating non-compliance with the minimum market value of listed securities requirement ($35 million). The company's current market capitalization is significantly below this threshold, highlighting a substantial challenge to regain compliance. While there is a 180-day period to address this, failure to do so could lead to delisting, which would severely impact the company's visibility, liquidity, and ability to raise capital. Investors should monitor the company's strategies and progress in meeting the Nasdaq requirements, as delisting would be a major negative event.
At the time of this filing, GOCO was trading at $1.52 on NASDAQ in the Finance sector, with a market capitalization of approximately $24.5M. The 52-week trading range was $1.31 to $14.14. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.